Holbrook E Kohrt

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi An ecological-transactional model of significant risk factors for child psychopathology in outer mongolia
    Holbrook E Kohrt
    Division of Child and Adolescent Psychiatry and Child Development, Stanford University School of Medicine, 401 Quarry Road, MC 5719, Stanford, CA 94305, USA
    Child Psychiatry Hum Dev 35:163-81. 2004
  2. ncbi New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
    Holbrook E Kohrt
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    BMC Cancer 8:66. 2008
  3. ncbi Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
    Holbrook E Kohrt
    Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA
    J Clin Invest 122:1066-75. 2012
  4. ncbi Treatment advances have not improved the early death rate in acute promyelocytic leukemia
    James Scott McClellan
    Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305 5821, USA
    Haematologica 97:133-6. 2012
  5. ncbi Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
    Ash A Alizadeh
    Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA
    Blood 118:1350-8. 2011
  6. ncbi CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD
    Suparna Dutt
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Blood 117:3230-9. 2011
  7. ncbi CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
    Holbrook E Kohrt
    Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Blood 117:2423-32. 2011
  8. ncbi Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes
    A Francesca Setiadi
    Department of Medicine, Stanford University School of Medicine, Stanford, California, United States of America
    PLoS ONE 5:e12420. 2010
  9. ncbi Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
    Mark P Chao
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, and Ludwig Center at Stanford, Stanford University, Palo Alto, CA 94304, USA
    Cell 142:699-713. 2010
  10. ncbi Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells
    Matthew J Goldstein
    Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Cancer Res 72:1239-47. 2012

Detail Information

Publications21

  1. ncbi An ecological-transactional model of significant risk factors for child psychopathology in outer mongolia
    Holbrook E Kohrt
    Division of Child and Adolescent Psychiatry and Child Development, Stanford University School of Medicine, 401 Quarry Road, MC 5719, Stanford, CA 94305, USA
    Child Psychiatry Hum Dev 35:163-81. 2004
    ..Structural equation modeling provides a useful technique to isolate specific sites for intervention, while maintaining a comprehensive perspective of risk factor interaction...
  2. ncbi New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
    Holbrook E Kohrt
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    BMC Cancer 8:66. 2008
    ..Our goal was to develop new models to quantify the risk of NSLN metastasis in SLN-positive patients and to compare predictive capabilities to another widely used model...
  3. ncbi Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
    Holbrook E Kohrt
    Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA
    J Clin Invest 122:1066-75. 2012
    ....
  4. ncbi Treatment advances have not improved the early death rate in acute promyelocytic leukemia
    James Scott McClellan
    Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305 5821, USA
    Haematologica 97:133-6. 2012
    ..Our findings show that early death is now the greatest contributor to treatment failure in this otherwise highly curable form of leukemia...
  5. ncbi Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
    Ash A Alizadeh
    Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA
    Blood 118:1350-8. 2011
    ..We conclude that the measurement of a single gene expressed by tumor cells (LMO2) and a single gene expressed by the immune microenvironment (TNFRSF9) powerfully predicts overall survival in patients with DLBCL...
  6. ncbi CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD
    Suparna Dutt
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Blood 117:3230-9. 2011
    ..In conclusion, the memory CD8(+) T-cell subset separated graft antilymphoma activity from GVHD more effectively than naive T cells, memory CD4(+) T cells, or memory total T cells...
  7. ncbi CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
    Holbrook E Kohrt
    Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Blood 117:2423-32. 2011
    ..These results support a novel, sequential antibody approach against B-cell malignancies by targeting first the tumor and then the host immune system...
  8. ncbi Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes
    A Francesca Setiadi
    Department of Medicine, Stanford University School of Medicine, Stanford, California, United States of America
    PLoS ONE 5:e12420. 2010
    ..To gain additional mechanistic and prognostic insights, a need for quantitative architectural analysis arises in studying immune cell-cancer interactions within the tumor microenvironment and tumor-draining lymph nodes (TDLNs)...
  9. ncbi Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
    Mark P Chao
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, and Ludwig Center at Stanford, Stanford University, Palo Alto, CA 94304, USA
    Cell 142:699-713. 2010
    ..These antibodies synergized through a mechanism combining Fc receptor (FcR)-dependent and FcR-independent stimulation of phagocytosis that might be applicable to many other cancers...
  10. ncbi Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells
    Matthew J Goldstein
    Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Cancer Res 72:1239-47. 2012
    ..In conclusion, our findings identify 2 surface markers that can be used to facilitate the enrichment of antitumor CD4 T cells while depleting an inhibitory T(reg) population...
  11. ncbi Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer
    Holbrook E Kohrt
    Division of Hematology, Department of Medicine, Stanford University, Stanford, California, USA
    PLoS Med 2:e284. 2005
    ..CONCLUSION: These findings demonstrate that the immune profile of tumor-draining lymph nodes is of novel biologic and clinical importance for patients with early stage breast cancer...
  12. ncbi Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience
    Holbrook E Kohrt
    Department of Medicine, Division of Hematology, Stanford University, Stanford, CA 94305, USA
    Am J Hematol 85:877-81. 2010
    ..3 and 7.6 months, P = 0.36). Despite risk stratification by the European Prognostic Index, our series demonstrates inferior rates of response and survival, illustrating the limited activity of this regimen in our cohort...
  13. ncbi Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia
    Bruno C Medeiros
    Department of Medicine, Division of Hematology, Stanford University School of Medicine, California, USA
    Am J Hematol 87:45-50. 2012
    ..The trial was registered on www.ClinicalTrials.gov as #NCT00611247...
  14. ncbi Cytotoxic T lymphocyte responses against melanocytes and melanoma
    Gwendolen Y Chang
    Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California, USA
    J Transl Med 9:122. 2011
    ..To uncouple vitiligo from melanoma destruction, it is important to understand if CTLs can respond against melanoma and melanocytes at different levels...
  15. ncbi Acute myeloid leukaemia in the elderly: a review
    Daniel A Pollyea
    Divisions of Hematology and Oncology, Department of Internal Medicine, University Cancer Center, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
    Br J Haematol 152:524-42. 2011
    ..Elderly patients, with their narrow therapeutic window, are well positioned to derive a benefit from these novel agents, and therefore, despite a difficult past, there are reasons to be optimistic about the future of elderly AML...
  16. ncbi NKT cells, Treg, and their interactions in bone marrow transplantation
    Holbrook E Kohrt
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Eur J Immunol 40:1862-9. 2010
    ..In addition, we also examine the interactions between NKT cells and Treg in the context of BMT, and integrate the data from murine experimental models with the observations made in humans...
  17. ncbi TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
    Holbrook E Kohrt
    Department of Medicine, Stanford University School of Medicine, CA 94305, USA
    Blood 114:1099-109. 2009
    ..Active trial registration currently at clinicaltrials.gov under IDs of NCT00185640 and NCT00186615...
  18. ncbi Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
    Roch Houot
    Department of Medicine, Division of Oncology, Stanford University, CA, USA
    Blood 114:3431-8. 2009
    ..Moreover, the antitumor activity of anti-CD137 mAb could be further enhanced by depletion of regulatory T cell (T(regs)). These results support the evaluation of anti-CD137 therapy in clinical trials for patients with lymphoma...
  19. ncbi Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)
    Bruno C Medeiros
    Department of Medicine, Division of Hematology, Stanford University, Stanford, CA, USA
    Leuk Res 34:594-7. 2010
    ..2). Differential karyotype and expression of certain antigens were noted in patients with de novo AML with inv(3)(q21q26.2) vs. those with inv(3)(q21q26.2)-containing blasts...
  20. ncbi Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses
    Holbrook E Kohrt
    Department of Medicine, Division of Hematology, Stanford University, Stanford, California 94305, USA
    J Immunother (1997) 28:297-305. 2005
    ..Techniques, as presented here, that rapidly assess the overall antigen sensitivity, recognition efficiency, and functional status of patients' T-cell responses will guide future vaccine trials and immunotherapies...
  21. ncbi Distribution of distress in post-socialist Mongolia: a cultural epidemiology of yadargaa
    Brandon A Kohrt
    Department of Anthropology, Emory University, 1557 Pierce Drive, Atlanta, GA 30322, USA
    Soc Sci Med 58:471-85. 2004
    ..In conclusion, yadargaa strongly associates with disenfranchised groups in the capitalist economy. As a culturally constructed indicator of quality of life, yadargaa is a window into the lives of women and men in post-socialist Mongolia...